Description
Product Specifications
COA
IFU
Instrument
Description
The anti-Mullerian hormone (AMH) is a dimeric glycoprotein belonging to the transformed growth factor β (TGF-β) family, involved in the regulation of tissue growth and differentiation. Prior to secretion, the hormone undergoes glycosylation and dimerization to produce an approximately 140 kD precursor of two identical disulfidelinked 70 kD subunits. Each monomer contains a large N-erminal proregion and a much smaller C-terminal mature domain. In males, AMH is secreted by the Sertoli cells of the testes. During embryonic development in males, secretion of AMH from testicular Sertoli cells is responsible for the regression of the Mullerian duct and the normal development of the male reproductive tract. The secretion of AMH by the Sertoli cells starts during the embryogenesis and continues throughout life. In females, AMH plays a vital role in the follicle development of the ovary. AMH expression in granulosa cells starts in primary follicles and is maximal in granulosa cells of preantral and small antral follicles up to approximately 6 mm in diameter. Serum levels of AMH are barely detectable at birth in females, reach their highest levels after puberty, decrease progressively thereafter with age, and become undetectable at menopause. In clinical, AMH has been a surrogate biomarker in diagnosis of polycystic ovary syndrome (PCOS).
Product Specifications
Intended Use
Anti-Mullerian Hormone Assay Kit is a chemiluminescent microparticle immunoassay (CMIA) for the quantitative determination of Anti-Mullerian Hormone (AMH) in human serum and plasma. The assay kit is intended for in vitro diagnostic use.
Principle
The Anti-Mullerian Hormone assay is a quantitative sandwich immunoassay to determine the presence of AMH in human serum and plasma using CMIA technology with flexible assay protocols.
- Sample, and paramagnetic anti-AMH coated microparticles are mixed, AMH present in the sample binds to anti-AMH coated microparticles, forming an antigen antibody complex.
- After incubation, a conjugate containing acridinium-labeled anti-AMH is added to the reaction mixture and binds to unoccupied binding sites of the anti-AMH coated microparticles.
- After further incubation and washing, Pre-Trigger and Trigger Solutions are added to the reaction mixture.
- The resulting chemiluminescent reaction is measured as relative light units (RLUs). There is a relationship between the amount of AMH in the sample and the RLUs detected by the Optical system. Results are calculated automatically based on the previously established calibration curve.
Storage
The kit should be stored upright, not upside down or horizontally. Store at 2–8°C with a validity period of 12 months.
COA
IFU
Instrument